U-Ploid Biotechnologies

Restoring fertility to aged eggs

What is the Challenge?

Age-related fertility decline is a significant global health issue affecting millions of women. A major contributor to this decline is the deterioration in egg quality as women age, which significantly reducing their chances of conceiving. Current treatments offer limited success, leaving a significant unmet need in reproductive healthcare.

What is the Solution?

U-Ploid Biotechnologies is pioneering a revolutionary approach to address the root cause of age-related infertility. Their proprietary technology has demonstrated remarkable promise in preclinical studies, drastically improving egg quality to levels comparable to peak fertility in youth, pioneering a new era in fertility treatment. By targeting the underlying biological mechanisms, U-Ploid aims to revolutionize fertility healthcare and offer hope to those struggling to conceive.

This scientific breakthrough has the potential to transform the lives of millions by enhancing the success rates of in vitro fertilization (IVF) and reduce the emotional and financial burdens associated with multiple treatment cycles. U-Ploid’s innovative approach not only addresses age-related decline in egg quality, but also paves the way for more effective and accessible fertility solutions worldwide.